Fingerprint
Dive into the research topics of 'Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancer
Alexis LeVee, Kellie Spector, Brigid Larkin, Felipe Dezem, Jasmine Plummer, Farnaz Dadmanesh, Sujata Patil, Heather L. McArthur
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations